InsiderPulse| Date | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | Griffin Stephen D. | Director & President and CEO | Purchase | 12.2K | $12.29 | $150K | 36.2K | View ↗ |
No annual data found.
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
Bullish On Anika Therapeutics's Pullback As Integrity Scales
Anika Therapeutics, Inc. Q1 2026 Earnings Call Summary
Anika maintains 2026 revenue guidance of $114M-$122.5M while highlighting Integrity growth and Hyalofast FDA response work